Patent · US Active

Lentiviral vector-based vaccine

US8158413B2 · kind B2 · utility

1Cited by

2References

22Claims

0Family size

Assignee

INSTITUT PASTEUR · FR

Inventors

Pierre Charneau · Paris, FR
Philippe Despres · Colombes, FR

Key dates

Filing date	Oct 17, 2005
Grant date	Apr 17, 2012
Priority date	—
Expiry date	Jun 4, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of eliciting humoral responses, methods of immunization, and methods of vaccination using lentiviral vector are disclosed. Additionally, immunogenic compositions and vaccines for West Nile Virus are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.